Condition: Nasal Polyps · Sponsor: Rigshospitalet, Denmark
In this RCT the investigators randomize patients who are treated with biologic treatment (Nucala or Dupixent) due to nasal polyps and have controlled disease within the last year to either stop treatment og continue as a control group.
This description comes directly from the study's public registry record.
Kasper Aanæs, md, phd · 60708594 · kasperaanaes@hotmail.com
Always discuss trial participation with your own doctor first.
| Rigshospitalet | Copenhagen, Region H, Denmark | Recruiting |
| Nordsjællands hospital | Hillerød, Region H, Denmark | Recruiting |
| Køge øre næse hals afd | Køge, Region Sj, Denmark | Recruiting |
| Dept. of otorhinolaryngology, Odense | Odense, Region Syd, Denmark | Recruiting |
| Vejle sygehus | Vejle, Region S, Denmark | Recruiting |
| Gødstrup Hospital | Gødstrup, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07268313